A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability Journal Article


Authors: Bellone, S.; Roque, D. M.; Siegel, E.R.; Buza, N.; Hui, P.; Bonazzoli, E.; Guglielmi, A.; Zammataro, L.; Nagarkatti, N.; Zaidi, S.; Lee, J.; Silasi, D. A.; Huang, G. S.; Andikyan, V.; Damast, S.; Clark, M.; Azodi, M.; Schwartz, P. E.; Tymon‐Rosario, J. R.; Harold, J. A.; Mauricio, D.; Zeybek, B.; Menderes, G.; Altwerger, G.; Ratner, E.; Alexandrov, L. B.; Iwasaki, A.; Kong, Y.; Song, E.; Dong, W.; Elvin, J. A.; Choi, J.; Santin, A. D.
Article Title: A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Journal Title: Cancer
Volume: 128
Issue: 6
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2022-03-15
Start Page: 1206
End Page: 1218
Language: English
DOI: 10.1002/cncr.34025
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 34875107
PMCID: PMC9465822
DOI/URL:
Notes: Accession Number: 155474158 -- Entry Date: In Process -- Revision Date: 20220303 -- Publication Type: Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 0374236. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Samir Zaidi
    27 Zaidi